Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1987

AUTHORS

Petar Alaupovic , Marcelo Tavella , James Fesmire

ABSTRACT

The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complex lipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E). More... »

PAGES

7-14

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2

DOI

http://dx.doi.org/10.1007/978-1-4684-1268-0_2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049409530

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3591557


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apolipoproteins B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperlipoproteinemias", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoelectrophoresis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precipitin Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Binding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reference Values", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Oklahoma Medical Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma\u00a0USA, 73104"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alaupovic", 
        "givenName": "Petar", 
        "id": "sg:person.077536524.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077536524.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oklahoma Medical Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma\u00a0USA, 73104"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tavella", 
        "givenName": "Marcelo", 
        "id": "sg:person.01145621773.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145621773.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oklahoma Medical Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma\u00a0USA, 73104"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fesmire", 
        "givenName": "James", 
        "id": "sg:person.0707005107.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1042/bj1300913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004846153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj1300913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004846153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(72)90018-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005435319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(72)90018-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005435319"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008362783", 
          "https://doi.org/10.1007/bf01747745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008362783", 
          "https://doi.org/10.1007/bf01747745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0003-9861(86)90112-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017120883"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(85)90037-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019152104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(85)90037-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019152104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci106085", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025378034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198505163122007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026919558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj1370155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037479416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/bj1370155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037479416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-4347(00)84488-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040816661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-3233(08)60220-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046638485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(83)90172-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052731818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2760(83)90172-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052731818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00751a011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055187400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00763a027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055187795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00768a015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055187931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080301373", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081722523", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1987", 
    "datePublishedReg": "1987-01-01", 
    "description": "The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complex lipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E).", 
    "editor": [
      {
        "familyName": "Malmendier", 
        "givenName": "C. L.", 
        "type": "Person"
      }, 
      {
        "familyName": "Alaupovic", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-1268-0_2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2436736", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": {
      "isbn": [
        "978-1-4684-1270-3", 
        "978-1-4684-1268-0"
      ], 
      "name": "Lipoproteins and Atherosclerosis", 
      "type": "Book"
    }, 
    "name": "Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias", 
    "pagination": "7-14", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-1268-0_2"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "eb60453c0dd9ad3c899175bd3e3d355a188674df01d1c3845c13d793a80664fa"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049409530"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3591557"
        ]
      }
    ], 
    "publisher": {
      "location": "Boston, MA", 
      "name": "Springer US", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-1268-0_2", 
      "https://app.dimensions.ai/details/publication/pub.1049409530"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-15T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000274.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-1-4684-1268-0_2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-1268-0_2'


 

This table displays all metadata directly associated to this object as RDF triples.

185 TRIPLES      23 PREDICATES      56 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-1268-0_2 schema:about N08ba3967699b4231a825b1148d0f2589
2 N0f48b8a5716d4ea8bcfc6696b2570c52
3 N466c9301a48048ff948409cca9f3d148
4 N678a008ba88f4e9aad069232d1819f7f
5 N744a16acb2684b5390e70f89030b7a95
6 N85d6091c11c24b7bb3014186c80c4766
7 Na4a981184603447b895f7cded70ef9bc
8 Na4b621e84337492f93b6673e82b6d5f0
9 Nb780725961b3497d8cc5979f48efbed0
10 Nd200f6579a724c6cb2a1662a87be2ff9
11 Ne3041acd1c874ce38e2e093518d57550
12 Nee1ca83932ef469fb7883d1aaf4f0ea0
13 anzsrc-for:11
14 anzsrc-for:1101
15 schema:author Na923185002634e4ca46da6080a9abd8c
16 schema:citation sg:pub.10.1007/bf01747745
17 https://app.dimensions.ai/details/publication/pub.1080301373
18 https://app.dimensions.ai/details/publication/pub.1081722523
19 https://doi.org/10.1016/0003-9861(86)90112-8
20 https://doi.org/10.1016/0005-2760(72)90018-5
21 https://doi.org/10.1016/0005-2760(83)90172-8
22 https://doi.org/10.1016/0005-2760(85)90037-2
23 https://doi.org/10.1016/s0065-3233(08)60220-x
24 https://doi.org/10.1016/s0378-4347(00)84488-6
25 https://doi.org/10.1021/bi00751a011
26 https://doi.org/10.1021/bi00763a027
27 https://doi.org/10.1021/bi00768a015
28 https://doi.org/10.1042/bj1300913
29 https://doi.org/10.1042/bj1370155
30 https://doi.org/10.1056/nejm198505163122007
31 https://doi.org/10.1172/jci106085
32 schema:datePublished 1987
33 schema:datePublishedReg 1987-01-01
34 schema:description The operationally-defined plasma lipoproteins have provided the theoretical basis for most studies and current views on the mechanism of lipid transport [1,2]. The popularity of these classification systems has been enhanced by clinical studies which have related certain derangements of lipid transport to particular density classes or electrophoretic patterns [2,3]. However, the discovery of a number of apolipoproteins [1,4] and the detection of marked protein heterogeneity of lipoprotein density classes and electrophoretic bands [4,5] have become incompatible with the view that operationally-defined lipoproteins represent the fundamental chemical and metabolic entities of lipid transport system. Results from laboratories have shown that major density classes consist of several distinct lipoprotein families or particles rather than single lipid-protein complexes [4-9]. Based on these and similar findings showing that lipoprotein density classes consist of distinct lipoprotein particles of similar hydrated densities but different apolipoprotein composition, we have proposed that apo-lipoproteins be used as specific markers for the identification of lipoprotein particles and as a new means for the classification of plasma lipoproteins [10,11]. According to this proposal, lipoprotein families or particles which contain a single apolipoprotein are called simple lipoproteins and those which contain two or more apolipoproteins are referred to as complex lipoproteins [11]. The nomenclature of lipoprotein particles is based on the ABC nomenclature of apolipoproteins [10] in that lipoprotein particles are named after their constitutive apolipoproteins. For example, lipoprotein particles which only contain ApoB as their protein moiety are called lipoprotein B (LP-B), while lipoprotein particles which contain apolipoproteins B, C and E are named lipoprotein B:C:E (LP-B:C:E).
35 schema:editor N2d16f81f374b4493ac1bb2f49997f122
36 schema:genre chapter
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf Ncfe296d45f3a4767b1eced2f4507b5e5
40 schema:name Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias
41 schema:pagination 7-14
42 schema:productId N28875d7c3b814d57999d3ec84c459849
43 N689ebadc0e2f453a9c08bf47fb79d976
44 Naa3d4c205e99492eb0741e8bc5090be3
45 Nc1622b39518e43ffb63b124e25c37e61
46 schema:publisher Nc4afea779ae04742bc22a0814b1ff180
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049409530
48 https://doi.org/10.1007/978-1-4684-1268-0_2
49 schema:sdDatePublished 2019-04-15T15:24
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N1cb941d3a21c4044827156b3134b79fb
52 schema:url http://link.springer.com/10.1007/978-1-4684-1268-0_2
53 sgo:license sg:explorer/license/
54 sgo:sdDataset chapters
55 rdf:type schema:Chapter
56 N08ba3967699b4231a825b1148d0f2589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Precipitin Tests
58 rdf:type schema:DefinedTerm
59 N0f48b8a5716d4ea8bcfc6696b2570c52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Protein Binding
61 rdf:type schema:DefinedTerm
62 N1cb941d3a21c4044827156b3134b79fb schema:name Springer Nature - SN SciGraph project
63 rdf:type schema:Organization
64 N209ca49cb77345a98e55c0e4899d7f1d rdf:first N8ffff9afec4e40899c53e366feba3a2c
65 rdf:rest rdf:nil
66 N28875d7c3b814d57999d3ec84c459849 schema:name doi
67 schema:value 10.1007/978-1-4684-1268-0_2
68 rdf:type schema:PropertyValue
69 N2d16f81f374b4493ac1bb2f49997f122 rdf:first N4a564ce4cf9f48d59288c52e42de702d
70 rdf:rest N209ca49cb77345a98e55c0e4899d7f1d
71 N466c9301a48048ff948409cca9f3d148 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Adult
73 rdf:type schema:DefinedTerm
74 N4a564ce4cf9f48d59288c52e42de702d schema:familyName Malmendier
75 schema:givenName C. L.
76 rdf:type schema:Person
77 N678a008ba88f4e9aad069232d1819f7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Lipoproteins
79 rdf:type schema:DefinedTerm
80 N689ebadc0e2f453a9c08bf47fb79d976 schema:name readcube_id
81 schema:value eb60453c0dd9ad3c899175bd3e3d355a188674df01d1c3845c13d793a80664fa
82 rdf:type schema:PropertyValue
83 N744a16acb2684b5390e70f89030b7a95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 N85d6091c11c24b7bb3014186c80c4766 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Immunoelectrophoresis
88 rdf:type schema:DefinedTerm
89 N8ffff9afec4e40899c53e366feba3a2c schema:familyName Alaupovic
90 schema:givenName P.
91 rdf:type schema:Person
92 Na299c69b5e6b43aca0cdc16b255e354a rdf:first sg:person.01145621773.36
93 rdf:rest Nc35019e248734ebcb1cffce7bfe20e5d
94 Na4a981184603447b895f7cded70ef9bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Hyperlipoproteinemias
96 rdf:type schema:DefinedTerm
97 Na4b621e84337492f93b6673e82b6d5f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Male
99 rdf:type schema:DefinedTerm
100 Na923185002634e4ca46da6080a9abd8c rdf:first sg:person.077536524.07
101 rdf:rest Na299c69b5e6b43aca0cdc16b255e354a
102 Naa3d4c205e99492eb0741e8bc5090be3 schema:name dimensions_id
103 schema:value pub.1049409530
104 rdf:type schema:PropertyValue
105 Nb780725961b3497d8cc5979f48efbed0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Humans
107 rdf:type schema:DefinedTerm
108 Nc1622b39518e43ffb63b124e25c37e61 schema:name pubmed_id
109 schema:value 3591557
110 rdf:type schema:PropertyValue
111 Nc35019e248734ebcb1cffce7bfe20e5d rdf:first sg:person.0707005107.03
112 rdf:rest rdf:nil
113 Nc4afea779ae04742bc22a0814b1ff180 schema:location Boston, MA
114 schema:name Springer US
115 rdf:type schema:Organisation
116 Ncfe296d45f3a4767b1eced2f4507b5e5 schema:isbn 978-1-4684-1268-0
117 978-1-4684-1270-3
118 schema:name Lipoproteins and Atherosclerosis
119 rdf:type schema:Book
120 Nd200f6579a724c6cb2a1662a87be2ff9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Reference Values
122 rdf:type schema:DefinedTerm
123 Ne3041acd1c874ce38e2e093518d57550 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Apolipoproteins B
125 rdf:type schema:DefinedTerm
126 Nee1ca83932ef469fb7883d1aaf4f0ea0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Middle Aged
128 rdf:type schema:DefinedTerm
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical Biochemistry and Metabolomics
134 rdf:type schema:DefinedTerm
135 sg:grant.2436736 http://pending.schema.org/fundedItem sg:pub.10.1007/978-1-4684-1268-0_2
136 rdf:type schema:MonetaryGrant
137 sg:person.01145621773.36 schema:affiliation https://www.grid.ac/institutes/grid.274264.1
138 schema:familyName Tavella
139 schema:givenName Marcelo
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145621773.36
141 rdf:type schema:Person
142 sg:person.0707005107.03 schema:affiliation https://www.grid.ac/institutes/grid.274264.1
143 schema:familyName Fesmire
144 schema:givenName James
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03
146 rdf:type schema:Person
147 sg:person.077536524.07 schema:affiliation https://www.grid.ac/institutes/grid.274264.1
148 schema:familyName Alaupovic
149 schema:givenName Petar
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077536524.07
151 rdf:type schema:Person
152 sg:pub.10.1007/bf01747745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008362783
153 https://doi.org/10.1007/bf01747745
154 rdf:type schema:CreativeWork
155 https://app.dimensions.ai/details/publication/pub.1080301373 schema:CreativeWork
156 https://app.dimensions.ai/details/publication/pub.1081722523 schema:CreativeWork
157 https://doi.org/10.1016/0003-9861(86)90112-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017120883
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/0005-2760(72)90018-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005435319
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/0005-2760(83)90172-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052731818
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/0005-2760(85)90037-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019152104
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/s0065-3233(08)60220-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046638485
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/s0378-4347(00)84488-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040816661
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1021/bi00751a011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055187400
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1021/bi00763a027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055187795
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1021/bi00768a015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055187931
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1042/bj1300913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004846153
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1042/bj1370155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037479416
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1056/nejm198505163122007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026919558
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1172/jci106085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025378034
182 rdf:type schema:CreativeWork
183 https://www.grid.ac/institutes/grid.274264.1 schema:alternateName Oklahoma Medical Research Foundation
184 schema:name Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma USA, 73104
185 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...